Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30245218 | 0.93 | ALDH1A1 (0.48) | QPCTALDH1A1TSHRMAPK1HRH3 | |
| SCHEMBL30245268 | 0.91 | QPCT (0.49) | QPCTALDH1A1TSHRMAPK1HRH3 | |
| SCHEMBL30245462 | 0.90 | QPCT (0.48) | QPCTALDH1A1TSHRMAOBSLC2A1 | |
| SCHEMBL30245592 | 0.87 | QPCT (0.50) | QPCTTSHRMAPK1MAOB | |
| SCHEMBL25253058 | 0.87 | HRH3 (0.49) | QPCTALDH1A1TSHRHRH3MAPT | |
| SCHEMBL30244917 | 0.87 | HRH3 (0.49) | QPCTALDH1A1TSHRHRH3MAPT | |
| SCHEMBL30245041 | 0.86 | QPCT (0.49) | QPCTALDH1A1TSHRMAPK1HRH3 | |
| SCHEMBL30244968 | 0.86 | QPCT (0.49) | QPCTTSHRMAPK1MAOB | |
| SCHEMBL25425381 | 0.85 | QPCT (0.72) | QPCTALDH1A1 | |
| SCHEMBL30245241 | 0.85 | ALDH1A1 (0.46) | QPCTALDH1A1TSHRMAPK1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | claimed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | disclosed |